Page last updated: 2024-12-06

1-naphthalenemethanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Naphthalenemethanol, also known as α-naphthylmethanol, is a white crystalline organic compound. It is a primary alcohol derived from naphthalene. It is commonly used as an intermediate in the synthesis of other organic compounds, including pharmaceuticals and dyes. 1-Naphthalenmethanol is a key building block for the synthesis of various naphthalene-based compounds. For example, it can be used to prepare naphthalene-containing polymers, which have applications in plastics, coatings, and adhesives. In addition, 1-naphthalenemethanol is a component of some fragrances and flavorings. It has been studied for its potential biological activities, including anti-inflammatory and antibacterial effects. Some research suggests that 1-naphthalenemethanol may have potential applications in the treatment of certain medical conditions, such as cancer. It is important to note that the use of 1-naphthalenemethanol in medicine is not fully established and further research is needed to confirm its safety and efficacy. 1-Naphthalenmethanol is a relatively stable compound and can be stored for long periods under appropriate conditions. It is generally considered non-toxic but may cause skin and eye irritation.'

1-naphthalenemethanol: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(1-naphthyl)methanol : A naphthylmethanol that is methanol in which one of the hydrogens of the methyl group is replaced by a naphthalen-1-yl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID20908
CHEMBL ID1288
CHEBI ID38137
SCHEMBL ID28403
MeSH IDM0143293

Synonyms (57)

Synonym
nsc5315
nsc-5315
1-naphthalenemethanol
4780-79-4
brn 2042532
1-naphthylmethyl alcohol
nsc 5315
alpha-naphthylcarbinol
einecs 225-324-1
1-naphthylenemethanol
alpha-naphthylmethanol
1-menaphthyl alcohol
ai3-05977
naphthalene-1-methanol
DALC2-H_000044
inchi=1/c11h10o/c12-8-10-6-3-5-9-4-1-2-7-11(9)10/h1-7,12h,8h
1-naphthylmethanol
1-naphthalenemethanol, 98%
1-hydroxymethylnaphthalene
(naphthalen-1-yl)methanol
CHEBI:38137 ,
(1-naphthyl)methanol
AC-5790
naphthalen-1-yl-methanol
CHEMBL1288
AKOS000249366
naphthalen-1-ylmethanol
BMSE000690
1-naphthalene methanol
N0633
1-(hydroxymethyl)naphthalene
A15589
unii-4l2mej1q34
4l2mej1q34 ,
FT-0672627
FT-0605830
FS-3468
naphthylmethan-1-ol
.alpha.-naphthylmethanol
.alpha.-naphthylcarbinol
1-naphthylcarbinol
SCHEMBL28403
mfcd00004044
SY007270
1-(hydroxymethyl)naphthalin
(naphthalene-1-yl)-methanol
W-106063
1-naphthylmethanol #
DTXSID30197295
EN300-78703
Q27104433
BCP26817
CS-W017957
1-naphthylmethnol
SB66323
F14852
HY-W017241
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
naphthylmethanolA primary alcohol that is methanol in which one of the methyl hydrogens has been replaced by a naphthyl or a substituted naphthyl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sulfotransferase 1A1 Rattus norvegicus (Norway rat)Km30.00005.00007.571410.0000AID39219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID39219Apparent Michaelis constant (Km) against Arylsulfotransferase (AST IV)2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
AID624612Specific activity of expressed human recombinant UGT1A92000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID39220Maximal velocity (Vmax) against Arylsulfotransferase (AST IV)2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
AID229377Ratio of kcat/Km determined for catalytic efficiency in sulfonation against AST IV2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (70.00)18.7374
1990's1 (10.00)18.2507
2000's2 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.53 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.08 (4.65)
Search Engine Demand Index30.30 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]